142 related articles for article (PubMed ID: 36692828)
21. Plumbagin engenders apoptosis in lung cancer cells via caspase-9 activation and targeting mitochondrial-mediated ROS induction.
Tripathi SK; Rengasamy KRR; Biswal BK
Arch Pharm Res; 2020 Feb; 43(2):242-256. PubMed ID: 32034669
[TBL] [Abstract][Full Text] [Related]
22. The combination of plumbagin with androgen withdrawal causes profound regression of prostate tumors in vivo.
Abedinpour P; Baron VT; Chrastina A; Welsh J; Borgström P
Prostate; 2013 Apr; 73(5):489-99. PubMed ID: 22996809
[TBL] [Abstract][Full Text] [Related]
23. A potential anti-tumor herbal medicine, Corilagin, inhibits ovarian cancer cell growth through blocking the TGF-β signaling pathways.
Jia L; Jin H; Zhou J; Chen L; Lu Y; Ming Y; Yu Y
BMC Complement Altern Med; 2013 Feb; 13():33. PubMed ID: 23410205
[TBL] [Abstract][Full Text] [Related]
24. Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-kappaB and Bcl-2.
Ahmad A; Banerjee S; Wang Z; Kong D; Sarkar FH
J Cell Biochem; 2008 Dec; 105(6):1461-71. PubMed ID: 18980240
[TBL] [Abstract][Full Text] [Related]
25. Emerging role of plumbagin: Cytotoxic potential and pharmaceutical relevance towards cancer therapy.
Tripathi SK; Panda M; Biswal BK
Food Chem Toxicol; 2019 Mar; 125():566-582. PubMed ID: 30685472
[TBL] [Abstract][Full Text] [Related]
26. Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.
Kawiak A; Domachowska A; Lojkowska E
J Nat Prod; 2019 Apr; 82(4):878-885. PubMed ID: 30810041
[TBL] [Abstract][Full Text] [Related]
27. The anti-tumor effect and bioactive phytochemicals of Hedyotis diffusa willd on ovarian cancer cells.
Zhang L; Zhang J; Qi B; Jiang G; Liu J; Zhang P; Ma Y; Li W
J Ethnopharmacol; 2016 Nov; 192():132-139. PubMed ID: 27426510
[TBL] [Abstract][Full Text] [Related]
28. [Expression and significance of heparin binding-epidermal growth factor-like growth factor in paclitaxel-resistant ovarian cancer].
Tang X; Lu M; Li C; Deng S; Li M
Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):517-22. PubMed ID: 25327734
[TBL] [Abstract][Full Text] [Related]
29. Plumbagin shows anti-cancer activity in human breast cancer cells by the upregulation of p53 and p21 and suppression of G1 cell cycle regulators.
Zhang XQ; Yang CY; Rao XF; Xiong JP
Eur J Gynaecol Oncol; 2016; 37(1):30-5. PubMed ID: 27048106
[TBL] [Abstract][Full Text] [Related]
30. Chikusetsusaponin IVa methyl ester induces G1 cell cycle arrest, triggers apoptosis and inhibits migration and invasion in ovarian cancer cells.
Chen X; Wu QS; Meng FC; Tang ZH; Chen X; Lin LG; Chen P; Qiang WA; Wang YT; Zhang QW; Lu JJ
Phytomedicine; 2016 Dec; 23(13):1555-1565. PubMed ID: 27823619
[TBL] [Abstract][Full Text] [Related]
31. Plumbagin exerts an immunosuppressive effect on human T-cell acute lymphoblastic leukemia MOLT-4 cells.
Bae KJ; Lee Y; Kim SA; Kim J
Biochem Biophys Res Commun; 2016 Apr; 473(1):272-277. PubMed ID: 27018383
[TBL] [Abstract][Full Text] [Related]
32. Plumbagin inhibits cell growth and potentiates apoptosis in human gastric cancer cells in vitro through the NF-κB signaling pathway.
Li J; Shen L; Lu FR; Qin Y; Chen R; Li J; Li Y; Zhan HZ; He YQ
Acta Pharmacol Sin; 2012 Feb; 33(2):242-9. PubMed ID: 22231395
[TBL] [Abstract][Full Text] [Related]
33. Plumbagin induces apoptosis in human osteosarcoma through ROS generation, endoplasmic reticulum stress and mitochondrial apoptosis pathway.
Chao CC; Hou SM; Huang CC; Hou CH; Chen PC; Liu JF
Mol Med Rep; 2017 Oct; 16(4):5480-5488. PubMed ID: 28849158
[TBL] [Abstract][Full Text] [Related]
34. [Effects of plumbagin on the human acute promyelocytic leukemia cells in vitro].
Zhao YL; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):208-11. PubMed ID: 16638181
[TBL] [Abstract][Full Text] [Related]
35. Plumbagin enhances TRAIL-mediated apoptosis through up-regulation of death receptor in human melanoma A375 cells.
Li J; Shen Q; Peng R; Chen R; Jiang P; Li Y; Zhang L; Lu J
J Huazhong Univ Sci Technolog Med Sci; 2010 Aug; 30(4):458-63. PubMed ID: 20714870
[TBL] [Abstract][Full Text] [Related]
36. Plumbagin inhibits growth of gliomas in vivo via suppression of FOXM1 expression.
Niu M; Cai W; Liu H; Chong Y; Hu W; Gao S; Shi Q; Zhou X; Liu X; Yu R
J Pharmacol Sci; 2015 Jul; 128(3):131-6. PubMed ID: 26154848
[TBL] [Abstract][Full Text] [Related]
37. Exploring the mechanisms of anti-ovarian cancer of Hedyotis diffusa Willd and Scutellaria barbata D. Don through focal adhesion pathway.
Xu X; Chen F; Zhang L; Liu L; Zhang C; Zhang Z; Li W
J Ethnopharmacol; 2021 Oct; 279():114343. PubMed ID: 34147618
[TBL] [Abstract][Full Text] [Related]
38. [Effect of estrogen or progesterone combined with paclitaxel on human ovarian cancer cell growth and Drosha expression].
Yang Y; Han K; Xie Y
Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):578-84. PubMed ID: 26714597
[TBL] [Abstract][Full Text] [Related]
39. Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines.
Huh SW; Bae SM; Kim YW; Lee JM; Namkoong SE; Lee IP; Kim SH; Kim CK; Ahn WS
Gynecol Oncol; 2004 Sep; 94(3):760-8. PubMed ID: 15350370
[TBL] [Abstract][Full Text] [Related]
40. Anticancer compound plumbagin and its molecular targets: a structural insight into the inhibitory mechanisms using computational approaches.
Jamal MS; Parveen S; Beg MA; Suhail M; Chaudhary AG; Damanhouri GA; Abuzenadah AM; Rehan M
PLoS One; 2014; 9(2):e87309. PubMed ID: 24586269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]